Deep Few-view High-resolution Photon-counting CT at Halved Dose for Extremity Imaging
Mengzhou Li, Chuang Niu, Ge Wang, Maya R Amma, Krishna M Chapagain, Stefan Gabrielson, Andrew Li, Kevin Jonker, Niels de Ruiter, Jennifer A Clark, Phil Butler, Anthony Butler, Hengyong Yu
TL;DR
This work tackles radiation-dose reduction in high-resolution extremity PCCT by introducing a deep learning–driven, patch-based volumetric reconstruction pipeline that combines a low-noise structural prior, deep iterative refinement (DIR) via an ADMM framework, and texture appearance tuning. The approach leverages a Volumetric Sparse Representation Network (VSR-Net) trained on synthetic data and refined with a model-based proximal operator, followed by Residual Fourier Channel Attention Network (RFCAN) post-processing to align texture with clinical references. By partitioning large volumes, using patch-based processing, and sharing a low-noise prior across channels, the method addresses memory and domain-gap challenges, achieving halved-dose and doubled-speed reconstruction validated in a NZ clinical trial. Phantom tests and an 8-patient reader study indicate comparable or superior diagnostic image quality and spectral fidelity relative to full-view reconstructions, supporting potential clinical translation for dose reduction in HR PCCT.
Abstract
X-ray photon-counting computed tomography (PCCT) for extremity allows multi-energy high-resolution (HR) imaging but its radiation dose can be further improved. Despite the great potential of deep learning techniques, their application in HR volumetric PCCT reconstruction has been challenged by the large memory burden, training data scarcity, and domain gap issues. In this paper, we propose a deep learning-based approach for PCCT image reconstruction at halved dose and doubled speed validated in a New Zealand clinical trial. Specifically, we design a patch-based volumetric refinement network to alleviate the GPU memory limitation, train network with synthetic data, and use model-based iterative refinement to bridge the gap between synthetic and clinical data. Our results in a reader study of 8 patients from the clinical trial demonstrate a great potential to cut the radiation dose to half that of the clinical PCCT standard without compromising image quality and diagnostic value.
